---

---

report   entities : Takeda pharmaceutical company limited   

save search

---

Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| Email alert Add to watchlist
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| Email alert Add to watchlist
MIRM | $23.6 -1.05% -1.06% 400K |

Health Technology

| Email alert Add to watchlist
report million reach treatment market

---

Plasma Therapy Global Market Report 2024 - Projected Compound Annual Growth Rate of 12.5%, with Market Set to Reach $0.88 Billion in 2028
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -10.72% | O: -0.2% H: 0.14% C: -0.48%
BAX | $39.65 0.33% 0.0% 2.3M |

Health Technology

| -5.99% | O: -0.38% H: 0.14% C: -0.14%
KMDA | $5.075 -0.1% -0.1% 6.5K |

Health Technology

| -15.22% | O: 2.0% H: 2.28% C: 1.63%
ADMA 4 | $6.21 2.82% 2.74% 3M |

Health Technology

| 19.69% | O: 0.19% H: 2.5% C: 1.35%
report reach global set therapy growth market

---

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49 |

Health Technology

| 12.7% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 9.56% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $57.3 0.02% 33K |

Professional, Scientific, and T...

| 15.41% | O: 4.07% H: 1.53% C: 1.45%
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| -1.04% | O: 0.56% H: 1.3% C: 1.22%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -8.23% | O: 0.42% H: 1.04% C: 0.97%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -8.08% | O: -0.91% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -4.32% | O: 0.89% H: 0.41% C: 0.1%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 1.05% | O: 0.38% H: 2.44% C: 1.54%
BAX | $39.65 0.33% 0.0% 2.3M |

Health Technology

| 0.2% | O: 0.33% H: 0.63% C: -0.28%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -5.33% | O: -0.73% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -5.49% | O: -0.83% H: 0.66% C: 0.38%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -1.43% | O: -1.1% H: 0.0% C: 0.0%
GLPG | $28.9 -1.1% -1.11% 140K |

Health Technology

| -25.19% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| -13.9% | O: 0.16% H: 0.43% C: -2.76%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 11.85% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -8.79% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

---

Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Published: 2024-02-13 (Crawled : 19:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -8.04% | O: 0.14% H: 0.35% C: 0.07%
XNCR | $18.98 -0.47% -0.47% 470K |

Health Technology

| -7.02% | O: -3.56% H: 2.91% C: -3.34%
MOR | $18.02 -0.11% -0.11% 590K |

Health Technology

| 4.15% | O: -0.4% H: 0.23% C: -0.46%
MGNX | $16.08 -0.12% -0.12% 590K |

Health Technology

| -10.16% | O: -5.25% H: 2.94% C: 2.18%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| -8.68% | O: 3.8% H: 1.1% C: -1.17%
financial

---

Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024
Published: 2024-02-07 (Crawled : 12:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -7.06% | O: 0.07% H: 0.42% C: 0.07%
NBIX M | $132.49 -0.56% -0.56% 550K |

Health Technology

| -6.81% | O: -5.57% H: 6.04% C: 0.96%
financial results

---

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K |

Health Technology

| -13.72% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $64.07 -4.38% 72K |

Manufacturing

| 37.02% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -14.23% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -7.06% | O: 0.07% H: 0.42% C: 0.07%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -6.93% | O: 1.47% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -1.95% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -3.43% | O: 1.48% H: 0.0% C: 0.0%
VRTX | News | $393.51 0.1% 0.1% 950K |

Health Technology

| -5.09% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -2.19% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $109.3 2.05% 2.01% 560K |

Health Technology

| -14.12% | O: -0.02% H: 0.0% C: -1.4%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -16.18% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

---

United States Endometrial Cancer Research Report 2023
Published: 2024-02-02 (Crawled : 10:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -8.48% | O: 0.21% H: 0.49% C: -0.9%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -11.63% | O: -0.5% H: 0.26% C: -1.03%
report cancer research

---

ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results
Published: 2023-11-02 (Crawled : 13:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -3.59% | O: 1.03% H: 0.73% C: 0.58%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 35.86% | O: 4.42% H: 0.0% C: 0.0%
IMGN | $31.23 0.03% 49M |

Health Technology

| 109.1% | O: 5.09% H: 5.48% C: -1.27%
financial results

---

Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-10-31 (Crawled : 00:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -1.5% | O: 1.05% H: 0.74% C: 0.74%
XNCR | $18.98 -0.47% -0.47% 470K |

Health Technology

| 10.68% | O: -0.41% H: 2.1% C: 1.11%
MOR | $18.02 -0.11% -0.11% 590K |

Health Technology

| 131.41% | O: 4.23% H: 0.12% C: -1.97%
MGNX | $16.08 -0.12% -0.12% 590K |

Health Technology

| 212.02% | O: 0.0% H: 2.13% C: 1.16%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| 1.27% | O: -0.39% H: 4.09% C: 3.8%
financial results

---

Global Hemophilia Research Analysis Report 2023: A $21.07 Billion Market by 2030 - Approval of Gene Therapies and Monoclonal Antibodies Fueling Growth
Published: 2023-08-16 (Crawled : 01:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -13.36% | O: -0.26% H: 0.26% C: -0.46%
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -28.17% | O: -0.71% H: 1.45% C: 0.97%
NVO | $122.75 -1.43% 0.0% 2.8M |

Health Technology

| 34.55% | O: -0.3% H: 1.35% C: 0.05%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -14.49% | O: -1.33% H: 0.0% C: 0.0%
report approval research global growth market

---

Arrowhead Pharmaceuticals Reports Fiscal 2023 Third Quarter Results
Published: 2023-08-07 (Crawled : 21:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -13.48% | O: 0.62% H: 0.62% C: 0.42%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 15.18% | O: 0.35% H: 0.41% C: 0.41%
ARWR | $22.62 0.4% 0.4% 1.3M |

Health Technology

| -25.21% | O: 0.0% H: 0.44% C: -2.65%
pharmaceuticals results

---

Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -13.76% | O: -2.23% H: 2.28% C: 1.34%
XNCR | $18.98 -0.47% -0.47% 470K |

Health Technology

| -21.49% | O: -0.74% H: 0.0% C: 0.0%
REPL | $6.98 -3.19% -3.3% 1.1M |

Health Technology

| -64.93% | O: 2.63% H: 1.14% C: -2.65%
MOR | $18.02 -0.11% -0.11% 590K |

Health Technology

| 145.58% | O: -0.14% H: 4.77% C: 4.77%
MGNX | $16.08 -0.12% -0.12% 590K |

Health Technology

| 237.53% | O: 0.0% H: 4.19% C: 2.31%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| -17.11% | O: 2.75% H: 0.44% C: -2.72%
financial results

---

Neurocrine Biosciences Reports Second Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -13.76% | O: -2.23% H: 2.28% C: 1.34%
NBIX M | $132.49 -0.56% -0.56% 550K |

Health Technology

| 30.76% | O: 0.6% H: 1.95% C: 0.92%
sales ingrezza financial results

---

Takeda Reports Strong First Quarter FY2023 Results, Driven by Growth & Launch Products
Published: 2023-07-27 (Crawled : 10:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -14.82% | O: 0.97% H: 1.35% C: 0.06%
fy2023 growth

---

Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $23.78 -0.96% -0.97% 1.8M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| Email alert Add to watchlist
NBIX M | $132.49 -0.56% -0.56% 550K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| Email alert Add to watchlist
UCBJY | $64.07 -4.38% 72K |

Manufacturing

| Email alert Add to watchlist
UCBJF | $126.05 -39.66% 100 |

Health Technology

| Email alert Add to watchlist
AZNCF | $140.15 -4.19% 560 |

Health Technology

| Email alert Add to watchlist
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| Email alert Add to watchlist
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| Email alert Add to watchlist
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| Email alert Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| Email alert Add to watchlist
report business life global therapeutics

---

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 11.2% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -16.55% | O: -0.95% H: 0.19% C: -0.32%
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -31.09% | O: 0.19% H: 0.11% C: -1.46%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -6.46% | O: -0.01% H: 0.16% C: -0.32%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -11.42% | O: 0.03% H: 0.12% C: -0.24%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 9.18% | O: -0.91% H: 0.56% C: -0.5%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 65.82% | O: 2.15% H: 1.18% C: 0.43%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -25.45% | O: -0.06% H: 0.46% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -4.83% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

---

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -7.89% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 14.25% | O: 1.32% H: 0.0% C: -0.62%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -18.21% | O: -0.62% H: 0.88% C: 0.81%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -5.5% | O: 1.26% H: 1.08% C: 0.91%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 15.25% | O: 0.41% H: 0.68% C: 0.64%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 72.05% | O: -0.11% H: 2.66% C: 2.24%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -25.87% | O: 0.28% H: 0.42% C: -0.05%
BNTX | $86.19 -0.24% -0.24% 580K |

Health Technology

| -21.24% | O: 0.39% H: 0.15% C: -0.79%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -6.88% | O: -0.23% H: 1.83% C: 1.52%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 19.74% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

---

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -8.59% | O: -0.56% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -8.39% | O: -0.74% H: 1.4% C: 0.35%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 15.61% | O: 0.99% H: 0.0% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -17.18% | O: 1.32% H: 0.31% C: 0.12%
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -33.14% | O: 0.6% H: 1.07% C: 0.29%
NVO | $122.75 -1.43% 0.0% 2.8M |

Health Technology

| -21.17% | O: -1.84% H: 1.62% C: 1.33%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -4.15% | O: 1.03% H: 0.84% C: 0.82%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -25.32% | O: 0.37% H: 1.34% C: 1.14%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -9.41% | O: 1.05% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -6.28% | O: 0.11% H: 0.69% C: -0.45%
report global therapeutics growth market

---

Global Addiction Treatment Market Report 2023: Sector to Reach $11.7 Billion by 2031 at a 6.1% CAGR
Published: 2023-05-26 (Crawled : 00:20) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
SYK | $327.45 -2.55% 0.0% 2.1M |

Health Technology

| Email alert Add to watchlist
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| Email alert Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| Email alert Add to watchlist
report reach treatment global market

---

Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published: 2023-05-15 (Crawled : 17:00) - prnewswire.com
GNMSF | $281.02 3.83% 210 |

Health Technology

| -33.14% | O: 0.24% H: 0.66% C: 0.66%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 7.89% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -19.66% | O: 0.61% H: 0.3% C: 0.24%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -9.75% | O: 0.2% H: 0.13% C: -0.22%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 8.4% | O: 0.27% H: 0.6% C: 0.41%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -15.86% | O: 0.38% H: 0.0% C: 0.0%
GMAB | $28.32 -0.74% -0.74% 240K |

Health Technology

| -31.57% | O: 0.38% H: 0.91% C: 0.69%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 13.73% | O: 0.14% H: 0.28% C: 0.11%
report cancer global therapy growth market

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---